Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Board Appointment

11th Apr 2006 07:00

Advanced Medical Solutions Grp PLC11 April 2006 For immediate release 11 April 2006 Advanced Medical Solutions Group plc ("AMS" or "the Company") Board Appointment Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalmedical technology company, today announces that Mr. Andrew Christopher Meredithhas been appointed to the Board as an Executive Director. Mr. Meredith, age 39, joined AMS in July 2005 as Group Commercial Director withthe objective of integrating sales, marketing, customer services and businessdevelopment across the Company. He formerly held senior commercial roles withinEurope with Banner Pharmacaps Inc. and Cardinal Health Inc. and gained medicaldevice experience with Smiths Group plc. This realignment has been completed and the commercial resources organised inline with the Company's market and partner focus. New Business Development VPshave been appointed to support European and US customers for the Company'sbranded partner business and the UK sales team has been strengthened behind theCompany's LiquiBandTM wound closure adhesive and ActivHeal(R) advanced woundcarerange, which are sold directly into the NHS. Mr Meredith has an interest in 500,000 shares in the Company allocated to himunder the Company's Long Term Incentive Plan. These were granted on 12 October2005. There are no other matters which are required to be announced with regardsto this appointment under paragraph (g) of Schedule 2 of the AIM Rules. Commenting on this announcement Dr. Geoffrey N. Vernon, Non-Executive Chairmanof AMS, stated: "Since joining AMS, Chris has made a major contribution to the continuedsuccessful commercialisation of the Company's technologies. His appointment tothe Board underlines the Board's confidence in his ability to continue to drivethe Company's future revenue and earnings growth." For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508Don Evans, Chief ExecutiveMary Tavener, Finance Directorwww.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $13 billion global woundcare market. Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions isfocused on the design, development and manufacture of innovative andtechnologically advanced products for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS' resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove from product design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives that offer benefits over sutures andstaples for closing wounds sold direct to hospitals or through distributors. AMS' technology and products currently serve the majority of the key globalmarkets and strategic partners. This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

Advanced Medical Solutions Group
FTSE 100 Latest
Value8,407.44
Change4.26